Naperville, IL -- (SBWIRE) -- 08/09/2012 -- The Global Breast Cancer Drugs market to grow at a CAGR of 1.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of breast cancer worldwide. The Global Breast Cancer Drugs market has also been witnessing the trend of the emergence of combination therapies to treat breast cancer effectively. However, the availability of alternative treatment methods could pose a challenge to the growth of this market.
The Global Breast Cancer Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Breast Cancer Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include AstraZeneca plc, Novartis, Roche Pharmaceuticals, and Sanofi S.A. Other vendors mentioned in the report: Eli Lilly and Co. and GlaxoSmithKline plc.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/88350/global-breast-cancer-drugs-market-2011-2015.html